We are live on ! Find out more
MEDS

DataMeds AI, Inc. Common Stock
MEDS

15 hedge funds and large institutions have $3.89M invested in DataMeds AI, Inc. Common Stock in 2025 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 1 increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

557% more capital invested

Capital invested by funds: $593K → $3.89M (+$3.3M)

300% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 3

150% more funds holding

Funds holding: 6 → 15 (+9)

0.09% more ownership

Funds ownership: 0.02% → 0.1% (+0.09%)

Holders
15
Holders Change
+9
Holders Change %
+150%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
1
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
HCM
Heights Capital Management
California
+$3.08M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$780K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$284K
4
OWP
ORG Wealth Partners
Texas
+$106K
5
State Street
State Street
Massachusetts
+$103K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$552K
2
Renaissance Technologies
Renaissance Technologies
New York
-$9.88K
3
Osaic Holdings
Osaic Holdings
Arizona
-$960
Name Holding Trade Value Shares
Change 		Change in
Stake
HCM
1
Heights Capital Management
California
$2.59M +$3.08M +58,342 New
Vanguard Group
2
Vanguard Group
Pennsylvania
$656K +$780K +14,785 New
Geode Capital Management
3
Geode Capital Management
Massachusetts
$239K +$284K +5,384 New
OWP
4
ORG Wealth Partners
Texas
$88.7K +$106K +2,000 New
State Street
5
State Street
Massachusetts
$86.3K +$103K +1,946 New
Northern Trust
6
Northern Trust
Illinois
$63.9K +$76K +1,440 New
Raymond James Financial
7
Raymond James Financial
Florida
$51.8K +$52.8K +1,000 +595%
UBS Group
8
UBS Group
Switzerland
$37.8K +$45K +853 New
XT
9
XTX Topco
Cayman Islands
$31.9K +$37.9K +719 New
VFIC
10
Valley Forge Investment Consultants
Pennsylvania
$20.4K – – –
TRCT
11
Tower Research Capital (TRC)
New York
$14.7K +$17.4K +330 New
JF
12
Jump Financial
Illinois
$14.4K +$17.1K +324 New
Citigroup
13
Citigroup
New York
$2K +$2.38K +45 New
Bank of America
14
Bank of America
North Carolina
$222 +$264 +5 New
GRP
15
Global Retirement Partners
California
$89 – – –
Morgan Stanley
16
Morgan Stanley
New York
$9 – – –
Millennium Management
17
Millennium Management
New York
– -$552K -11,391 Closed
Renaissance Technologies
18
Renaissance Technologies
New York
– -$9.88K -204 Closed
Osaic Holdings
19
Osaic Holdings
Arizona
– -$960 -20 Closed

MEDS Hedge Fund Activity: Q3 2025 in Review

15 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in DataMeds AI, Inc. Common Stock (MEDS) for Q3 2025, worth a combined $3.89M — up 557% from $593K a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new MEDS positions and 3 closed out — a net gain of 9 holders — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Heights Capital Management, opening a new position worth an estimated $3.08M. The largest seller was Millennium Management, exiting entirely with an estimated $552K sold.

  • 15 institutional investors held DataMeds AI, Inc. Common Stock (MEDS) as of Q3 2025, up from 6 in Q2 2025.
  • Funds reported $3.89M of DataMeds AI, Inc. Common Stock stock for Q3 2025, up 557% quarter-over-quarter.
  • 12 funds opened new DataMeds AI, Inc. Common Stock positions in Q3 2025 and 3 closed out, a net change of +9 holders.
  • The largest DataMeds AI, Inc. Common Stock buyer in Q3 2025 was Heights Capital Management, an estimated $3.08M added.
  • The largest DataMeds AI, Inc. Common Stock seller in Q3 2025 was Millennium Management, an estimated $552K sold.

Based on aggregated 13F filings for Q3 2025.